1
项与 Anti-CD19 CAR-T (University of Chulalongkorn) 相关的临床试验Safety/Phase I Study of PiggyBac Transposon Mediated Chimeric Antigen Receptor T Cells Targeting CD-19 in Thai Patients With Refractory Systemic Lupus Erythematosus
A Phase 1 clinical trial to evaluate the safety and efficacy of PiggyBac transposon-mediated Chimeric Antigen Receptor(CAR) T-cells targeting CD19 in refractory Systemic Lupus Erythematosus (SLE) patients who have not responded to standard immunosuppressive treatments.
100 项与 Anti-CD19 CAR-T (University of Chulalongkorn) 相关的临床结果
100 项与 Anti-CD19 CAR-T (University of Chulalongkorn) 相关的转化医学
100 项与 Anti-CD19 CAR-T (University of Chulalongkorn) 相关的专利(医药)
100 项与 Anti-CD19 CAR-T (University of Chulalongkorn) 相关的药物交易